NCT00037180View on ClinicalTrials.gov

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

PHASE2TerminatedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

January 31, 2003

Conditions
Neoplasm MetastasisColorectal Neoplasms
Interventions
DRUG

Celecoxib

DRUG

Irinotecan

DRUG

5-fluorouracil

DRUG

Leucovorin

Trial Locations (12)

14215

Pfizer Investigational Site, Buffalo

14221

Pfizer Investigational Site, Williamsville

16601

Pfizer Investigational Site, Altoona

33308

Pfizer Investigational Site, Fort Lauderdale

34952

Pfizer Investigational Site, Port Saint Lucie

36685

Pfizer Investigational Site, Mobile

53215

Pfizer Investigational Site, Milwaukee

60631

Pfizer Investigational Site, Chicago

63136

Pfizer Investigational Site, St Louis

64507

Pfizer Investigational Site, Saint Joseph

98372

Pfizer Investigational Site, Puyallup

98902

Pfizer Investigational Site, Yakima

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY